Defense stocks (Lockheed Martin, RTX, General Dynamics, Northrop Grumman, BAE Systems, etc.) are often discussed as conflict-period investments. The reality is more nuanced: defense procurement runs on multi-year cycles; immediate conflict often doesn't translate to near-term defense stock gains; political and ethical considerations introduce additional volatility.
This page covers how the sector actually behaves.
Major defense contracts take years to negotiate, fund, and deliver. A war breaking out today doesn't translate to revenue this quarter; impacts the contract pipeline 2-5 years out.
The 2022 Ukraine invasion did not produce a sudden surge in defense stock revenue; it shifted the long-term outlook for defense spending in NATO countries.
Defense budgets are political and economic decisions. Major budget increases happen during periods of perceived threat or strategic shifts; not necessarily aligned with active combat.
US defense spending has trended up regardless of specific conflicts in many recent decades.
Defense is a small set of large companies (top 5 in US dominate). Concentration risk is real.
For investors wanting "defense exposure," this often means picking among 5-10 companies — not really diversified within sector.
Major shifts (Reagan buildup; post-Cold War drawdown; post-9/11 increase; post-2022 European rearmament) drive multi-year stock trends.
Specific conflicts often have less impact than overall geopolitical posture.
Defense companies depend on government contracts:
For US defense companies, the US government is the dominant customer. Political shifts matter dramatically.
Some investors avoid defense for ethical reasons:
ESG funds often exclude defense; investors who care can find non-defense funds.
For investors who don't object: defense is a sector like any other.
For those who do: explicit avoidance possible.
Following the 2022 Ukraine invasion, NATO members committed to 2% of GDP defense spending. Many were below this; the catch-up represents multi-year revenue growth for defense companies.
European defense companies particularly benefited.
US defense industry is rebuilding capacity for some weapons (artillery, missiles) where production rates were below replacement after Cold War drawdown.
This is multi-year capex; benefits specific suppliers more than primes.
Defense supply chains have many sub-suppliers. Some are sole-source for specific components (chips, materials).
Investing in primes captures some of the upside; investing in sub-suppliers can capture more but with concentration risk.
Expense ratios 0.30-0.40%. Provide diversified exposure within sector.
For specific bets:
Each has different program exposure; concentration in specific weapons makes them more volatile than diversified ETFs.
European defense companies (Rheinmetall, BAE Systems, Thales) benefited from European rearmament more than US primes.
For pure-play European defense exposure: international ETFs or specific stock selection.
For broad-market investors, defense is included in standard market-cap-weighted indexes. No need to overweight unless you have a specific view.
Defense stocks often rise on conflict news; the rise reflects multi-year outlook, not near-term revenue. Buying on news often catches the top.
Companies range from pure defense (LMT, RTX) to mixed (Boeing has commercial + defense). Different exposures.
Defense spending is a political decision. Plan for potential cuts.
Top 5 companies dominate US defense. ETFs include them; concentration is real.
Some defense companies have varying ESG profiles. Generic exclusion misses nuance.